The stably integrated birA gene is induced by the addition of 0.2-0.4% L-arabinose. No antibiotics are required to maintain gene. The use of AVB100 with IPTG inducible vectors (e.g., pAC or pAN AviTag vectors) allows independent control over the expressed gene of interest and the BirA levels.
Quantity: 1 vial, containing 0.5 ml of glycerol stockPlease note: Strain AVB100 or derivatives when purchased conveys a limited use license to the end user. This license prohibits the purchaser from selling, assigning or transferring this product to any third party without the express written consent of Avidity, L.L.C. Please review this license on the specification sheet below before purchasing this product.